Details for 2019849948
Up to date per 01.04.2026
Actions
Details for 2019849948
Granted/Registered
European Patent
23.06.2021 A
01.10.2025 B1
17.08.2018
US
201862765154 P
A61K 31/415 20060101AFI20220309BHEP
Owner
Eidos Therapeutics, Inc.3160 Porter Drive Suite 250 Palo Alto, CA 94304US
Representative
No representatives present
Inventor
JERNELIUS, Jesper Palo Alto, CA 94304US
MENNING, Mark Michael Palo Alto, CA 94304US
Information about Fees